Medical expert of the article
New publications
Preparations
Inoculation from typhoid fever
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Typhoid fever is an intestinal infection, endemic in many developing countries. In recent years, epidemics of typhoid fever have been observed in a number of CIS countries, in Central Asia. According to WHO, more than 500,000 people die of typhoid fever every year. Most often, people are sick at the age of 5-19 years, so vaccination against typhoid should be given to schoolchildren in endemic areas.
Since the 1980s, the resistance of typhoid fever to levomycetin has increased dramatically , which makes it difficult and expensive to treat (the need for the use of cephalosporins of the 3rd generation and fluoroquinolones); in recent years, there have been reports of its stability of the causative agent and to ciprofloxacin.
Inoculation from typhoid fever: a characteristic of drugs
Typhoid vaccines registered in Russia
Vaccine |
Content |
Dosage |
TIFIVAK - dry alcohol vaccine, Russia |
Inactivated and lyophilized S. Typhi strain 4446. At 1 amp. - 5 billion microbial cells. Without preservative. Store at 2-8 ° |
Adults 2-fold s / c: 0.5 ml, after 25-35 days. -1,0 ml, revaccination in 2 years - 1,0 ml. |
VIANVAK - lipolysaccharide liquid, Russia |
Purified capsule vi-polysaccharide. In one dose for all ages (0.5 ml), 25 μg of B-antigen. Store at 2-8 ° |
From the age of 3 years, once p / k. Revaccination - every 3 years. |
Whole-cell typhoid vaccines were used in schoolchildren and adults with an efficacy of 51-88%, but their use is limited by reactogenicity. The effectiveness of polysaccharide vaccines reaches 70%, they provide immunity after 1-2 weeks, it persists for 2 years. A conjugated vaccine (with exotoxin P. Aeruginosa), immunogenic in 90% of children 2-5 years old, was created. Vaccination from typhoid is carried out according to epidemiological evidence from the age of 3-7 years (depending on the type of vaccine) and individuals at risk. Vaccination also tourists, traveling to Africa and Asia.
Adverse reactions and complications after inoculation from typhoid fever
The alcoholic dry vaccine is reactogenic, the temperature is> 38.6 °, infiltration> 50 mm is not more than 7% of the vaccinated. The general reaction appears after 5-6 hours with a duration of up to 48 hours, the local reaction lasts 3-4 days. Rarely does the shock develop. Reactions to VIANVAC are rare: subfebrile in 1-5% for 24-48 h, headache.
Attention!
To simplify the perception of information, this instruction for use of the drug "Inoculation from typhoid fever" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.
Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.